Abstract:Lung is one of the most common sites for bladder cancer to metastasize. Although the involvement of the epithelial-to-mesenchymal transition (EMT) in bladder cancer progression has been established, the mechanism of EMT induction remains unclear. In order to investigate this, T24-parental (P) and T24-lung (L) bladder cancer cells were obtained from primary tumors and lung metastatic sites of an animal model with orthotopic spontaneous metastatic bladder cancer, according to a protocol previously described. Compared with T24-P cells, mesenchymal-like T24-L cells exhibited an increased ability in tumor invasion and metastasis, as well as an increased expression of hypoxia-inducible factor (HIF)-1α, zinc finger E-box-binding homeobox 1 (ZEB1), vimentin and N-cadherin and lower level of cytokeratin 18 were observed. Mechanistically, it was identified that HIF-1α increases ZEB1 expression and subsequently regulates the expression of EMT-related genes in both HIF-1α knocking down by siRNA and gain-in HIF-1α by hypoxia culture cell models. In addition, the expression of HIF-1α and ZEB1 in bladder cancer tissues were increased compared with normal bladder epithelial tissues, as well as significantly increased in the high-grade, invasive and metastatic bladder cancer tissues compared with low-grade, superficial and non-metastatic bladder cancer tissues by using immune-histochemical staining assay. Notably, the protein level of HIF-1α was positively associated with that of ZEB1 in bladder cancer tissues. Results from the present study indicate that HIF-1α promotes ZEB1 expression and EMT in the T24-L human bladder cancer lung metastasis animal model, suggesting that HIF-1α serves an important function in the metastasis of bladder cancer, and HIF-1α and ZEB1 may be potential targets for inhibiting bladder metastasis in the future.

HIF-1α knockdown suppresses breast cancer metastasis via epithelial mesenchymal transition Abrogation

Silencing Of Atp6v1c1 Prevents Breast Cancer Growth And Bone Metastasis

[Impact of Hypoxia-Inducible Factor-1 on Tumor Invasion and Metastasis in Breast Cancer].

HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model

HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs

Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model.

Hypoxia-inducible Factor 1 and Breast Cancer Metastasis.

Correction: HIF-1-dependent Expression of Angiopoietin-Like 4 and L1CAM Mediates Vascular Metastasis of Hypoxic Breast Cancer Cells to the Lungs.

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy

EHD1 Promotes Breast Cancer Metastasis Through Upregulating HIF2a Expression Via Activating Mtor Pathway

Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis

Inhibitors of Hypoxia-Inducible Factor 1 Block Breast Cancer Metastatic Niche Formation and Lung Metastasis

Akt1 Silencing Inhibits Lung Metastasis of Murine Breast Cancer Cells

TP53I11 Suppresses Epithelial-Mesenchymal Transition and Metastasis of Breast Cancer Cells

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.

Lipid-laden Lung Mesenchymal Cells Foster Breast Cancer Metastasis Via Metabolic Reprogramming of Tumor Cells and Natural Killer Cells.

Suppression of Breast Cancer Metastasis Through the Inactivation of ADP-ribosylation Factor 1.

Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.

Hypoxia-Inducible Factor 1-Dependent Expression of Platelet-Derived Growth Factor B Promotes Lymphatic Metastasis of Hypoxic Breast Cancer Cells

TNF‐α inhibits breast cancer cells adhesion via HIF‐1α mediated VASP suppression